These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 23174190)

  • 21. Innate immunity meets with cellular stress at the IKK complex: regulation of the IKK complex by HSP70 and HSP90.
    Salminen A; Paimela T; Suuronen T; Kaarniranta K
    Immunol Lett; 2008 Apr; 117(1):9-15. PubMed ID: 18282612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmaceutical inhibition of glycogen synthetase kinase-3β reduces multiple myeloma-induced bone disease in a novel murine plasmacytoma xenograft model.
    Gunn WG; Krause U; Lee N; Gregory CA
    Blood; 2011 Feb; 117(5):1641-51. PubMed ID: 21123822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting Protein Kinases in Blood Cancer: Focusing on CK1α and CK2.
    Spinello Z; Fregnani A; Quotti Tubi L; Trentin L; Piazza F; Manni S
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33918307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinase inhibitors as potential agents in the treatment of multiple myeloma.
    Abramson HN
    Oncotarget; 2016 Dec; 7(49):81926-81968. PubMed ID: 27655636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New responsibilities for aged kinases in B-lymphomas.
    Piazza F; Manni S; Arjomand A; Visentin A; Trentin L; Semenzato G
    Hematol Oncol; 2020 Feb; 38(1):3-11. PubMed ID: 31782972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein kinase 2 (CK2): a potential regulator of immune cell development and function in cancer.
    Husain K; Williamson TT; Nelson N; Ghansah T
    Immunol Med; 2021 Sep; 44(3):159-174. PubMed ID: 33164702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review of Glycogen Synthase Kinase-3 (GSK3) inhibitors for cancers therapies.
    Thapa R; Gupta G; Bhat AA; Almalki WH; Alzarea SI; Kazmi I; Saleem S; Khan R; Altwaijry N; Dureja H; Singh SK; Dua K
    Int J Biol Macromol; 2023 Dec; 253(Pt 7):127375. PubMed ID: 37839597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Role of Endoplasmic Reticulum Stress-Glycogen Synthase Kinase-3 Signaling in Atherogenesis.
    Huang A; Patel S; McAlpine CS; Werstuck GH
    Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29848965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of taurine transport systems by protein kinase CK2 in mammalian cells.
    Lambert IH; Hansen DB
    Cell Physiol Biochem; 2011; 28(6):1099-110. PubMed ID: 22178999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Joining the cell survival squad: an emerging role for protein kinase CK2.
    Ahmed K; Gerber DA; Cochet C
    Trends Cell Biol; 2002 May; 12(5):226-30. PubMed ID: 12062170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathophysiology and pharmacological targeting of tumor-induced bone disease: current status and emerging therapeutic interventions.
    Labropoulou VT; Theocharis AD; Symeonidis A; Skandalis SS; Karamanos NK; Kalofonos HP
    Curr Med Chem; 2011; 18(11):1584-98. PubMed ID: 21428887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting NF-κB Signaling for Multiple Myeloma.
    Wong AH; Shin EM; Tergaonkar V; Chng WJ
    Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32781681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cellular biology of plasma cells: Unmet challenges and opportunities.
    Bonaud A; Khamyath M; Espéli M
    Immunol Lett; 2023 Feb; 254():6-12. PubMed ID: 36646289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correction to: Role of protein kinases CK1α and CK2 in multiple myeloma: regulation of pivotal survival and stress-managing pathways.
    Manni S; Carrino M; Piazza F
    J Hematol Oncol; 2018 Apr; 11(1):51. PubMed ID: 29622027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Casein kinase: the triple meaning of a misnomer.
    Venerando A; Ruzzene M; Pinna LA
    Biochem J; 2014 Jun; 460(2):141-56. PubMed ID: 24825444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The casein kinase 2 inhibitor, CX-4945, as an anti-cancer drug in treatment of human hematological malignancies.
    Chon HJ; Bae KJ; Lee Y; Kim J
    Front Pharmacol; 2015; 6():70. PubMed ID: 25873900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Casein kinase 1 and Wnt/β-catenin signaling.
    Cruciat CM
    Curr Opin Cell Biol; 2014 Dec; 31():46-55. PubMed ID: 25200911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein kinase CK2 and angiogenesis.
    Montenarh M
    Adv Clin Exp Med; 2014; 23(2):153-8. PubMed ID: 24913104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assemblies of JAG1 and JAG2 determine tracheobronchial cell fate in mucosecretory lung disease.
    Reynolds SD; Hill CL; Alsudayri A; Lallier SW; Wijeratne S; Tan ZH; Chiang T; Cormet-Boyaka E
    JCI Insight; 2022 Aug; 7(15):. PubMed ID: 35819850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein kinase CK2: a potential therapeutic target for diverse human diseases.
    Borgo C; D'Amore C; Sarno S; Salvi M; Ruzzene M
    Signal Transduct Target Ther; 2021 May; 6(1):183. PubMed ID: 33994545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.